NCT02537626 An Evaluation of Low Level Laser Light Therapy on Improving the Symptoms of Alzheimer's Disease Status COMPLETED Phase NA
NCT02537496 Enhancing Working Memory in Patients With Early Alzheimer's Disease Through the Use of rTMS Status COMPLETED Phase NA
NCT02534480 Neurogenetic Pharmaceuticals (NGP) 555 in Healthy Young Volunteers (Single-ascending Dose) Status COMPLETED Phase PHASE1
NCT02522091 Cerebral Substrates of Prospective Memory in Young and Its Disruption in Normal Aging and in Alzheimer's Disease: A Study in Anatomical MRI, Diffusion Tensor MRI and Functional MRI Status UNKNOWN Phase NA
NCT02521558 Effectiveness of Home-based Electronic Cognitive Therapy in Alzheimer's Disease Status TERMINATED Phase NA
NCT02520232 Pathological and Non-pathological Aging, Physical Activity, Genotype and Cognition Status COMPLETED Phase NA
NCT02506374 Development of Therapeutic Intervention for Sleep in Alzheimer/Caregiver Dyads Status WITHDRAWN Phase N/A
NCT02502253 BDPP Treatment for Mild Cognitive Impairment (MCI) and Prediabetes or Type 2 Diabetes Mellitus (T2DM) Status COMPLETED Phase PHASE1
NCT02502045 Effect of Therapeutic Light on Sleep, Circadian Rhythm, and Global Function in Women With Alzheimer's Status COMPLETED Phase NA
NCT02500784 Improving Beta-2 Adrenergic Signaling in Alzheimer's Disease Status WITHDRAWN Phase PHASE2
NCT02492529 Knowing and Remembering: Cognitive and Neural Influences of Familiarity on Recognition Memory in Early Alzheimer's Disease Status COMPLETED Phase NA
NCT02485730 Early Identification of Markers in Alzheimer's Families / ALFA Status ACTIVE_NOT_RECRUITING Phase N/A
NCT02484547 221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease Status TERMINATED Phase PHASE3
NCT02477800 221AD301 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease Status TERMINATED Phase PHASE3
NCT02471833 Health Evaluation in African Americans Using RAS Therapy Status COMPLETED Phase PHASE1/PHASE2